MIRA advances Ketamir-2 in the clinic for neuropathic pain while broadening development into neuropsychiatric disorders such as PTSD MIAMI, FLORIDA / ACCESS Newswire / September 16, 2025 / MIRA ...

MIRA Pharmaceuticals (MIRA) announced results demonstrating that its oral drug candidate Ketamir-2 restored normalized behavior in stressed animals within a validated model of post-traumatic stress ...

This report calls on those who oversee the funding and implementation of PTSD research to reject animal-based research on ...